New Validation and Clinical Outcome Data From Several Studies Using Nanosphere’s Infectious Disease Tests to be Presented at ECCMID 2014
[GlobeNewswire] – NORTHBROOK, Ill. — Nanosphere, Inc. , a company enhancing medicine through targeted molecular diagnostics, today announced that new validation and clinical outcome data for select Verigene(R) multiplex … moreView todays social media effects on NSPHView the latest stocks trending across Twitter. Click to view dashboardSee who Nanosphere is hiring next, click here to view […]